Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa (Q39511350)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2012
edit
Language Label Description Also known as
English
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
scientific article published on April 2012

    Statements

    Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa (English)
    Milagritos D Tapia
    Michael J Dallas
    Kristen D C Lewis
    Stephen B Rivers
    A Duncan Steele
    Tapia, M.D.
    0 references
    Armah, G.
    0 references
    Dallas, M.J.
    0 references
    Lewis, K.D.C.
    0 references
    Sow, S.O.
    0 references
    Levine, M.M.
    0 references
    Laserson, K.F.
    0 references
    Feikin, D.R.
    0 references
    Victor, J.C.
    0 references
    Ciarlet, M.
    0 references
    Neuzil, K.M.
    0 references
    Steele, A.D.
    0 references
    1 April 2012
    2012
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit